Q4 2017 Holdings
Filed 2018-02-07 | 12 holdings | $12.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Adma Biologics Inc(ADMA) | COM | 000899104 | $11.6M | 3,608,171 | 95.9% |
| Loxo Oncology Inc | COM | 548862101 | $289.5K | 3,438,920 | 2.4% |
| Aimmune Therapeutics Inc.(AIMT) | COM | 00900T107 | $84.7K | 2,240,000 | 0.7% |
| Viewray Inc.(VRAYQ) | COM | 92672L107 | $69.3K | 7,480,887 | 0.6% |
| Transenterix Inc. | COM NEW | 89366M201 | $19.1K | 9,889,352 | 0.2% |
| Entellus MED Inc | COM | 29363K105 | $12.9K | 528,655 | 0.1% |
| Cidara Therapeutics Inc. | COM | 171757107 | $6.9K | 1,021,148 | 0.1% |
| Syros Pharmaceuticals, Inc. | COM | 87184Q107 | $4.9K | 508,565 | 0.0% |
| Agile Therapeutics Inc(AGRXUSD) | COM | 00847L100 | $3.5K | 1,304,933 | 0.0% |
| Chimerix Inc.(CMRXEUR) | COM | 16934W106 | $2.2K | 472,943 | 0.0% |
| Pernix Therapeutics Hldgs Inc | DBCV 4.250% 4/0 | 71426VAK4 | $1.1K | $2,500,000 | 0.0% |
| Pernix Therapeutics Hldgs in | COM NEW | 71426V306 | $504 | 210,000 | 0.0% |